Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BFRI NASDAQ:IMAC NYSE:MTNB NASDAQ:NAOV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBFRIBiofrontera$0.85-2.4%$0.92$0.54▼$2.22$8.62M0.49256,200 shs58,395 shsIMACIMAC$0.08+4.2%$0.07$0.75▼$1.65$2.12M-0.88708,132 shs22,294 shsMTNBMatinas Biopharma$1.65-2.9%$1.41$0.47▼$4.25$8.39M1.41411,895 shs68,790 shsNAOVNanovibronix$6.93-9.4%$7.49$4.71▼$162.50$5.54M2.09602,267 shs351,458 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBFRIBiofrontera+3.98%+1.47%-6.37%+33.99%-30.34%IMACIMAC0.00%+13.89%+15.49%+87.21%-93.79%MTNBMatinas Biopharma-2.86%+3.66%-27.97%+88.91%+815.46%NAOVNanovibronix-28.50%+33.74%+30.55%-19.85%-90.33%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBFRIBiofrontera$0.85-2.4%$0.92$0.54▼$2.22$8.62M0.49256,200 shs58,395 shsIMACIMAC$0.08+4.2%$0.07$0.75▼$1.65$2.12M-0.88708,132 shs22,294 shsMTNBMatinas Biopharma$1.65-2.9%$1.41$0.47▼$4.25$8.39M1.41411,895 shs68,790 shsNAOVNanovibronix$6.93-9.4%$7.49$4.71▼$162.50$5.54M2.09602,267 shs351,458 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBFRIBiofrontera+3.98%+1.47%-6.37%+33.99%-30.34%IMACIMAC0.00%+13.89%+15.49%+87.21%-93.79%MTNBMatinas Biopharma-2.86%+3.66%-27.97%+88.91%+815.46%NAOVNanovibronix-28.50%+33.74%+30.55%-19.85%-90.33%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBFRIBiofrontera 3.00Buy$2.75223.53% UpsideIMACIMAC 0.00N/AN/AN/AMTNBMatinas Biopharma 2.00HoldN/AN/ANAOVNanovibronix 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBFRIBiofrontera$37.32M0.23N/AN/A$0.57 per share1.49IMACIMAC$15.22M0.14N/AN/A$0.69 per share0.12MTNBMatinas BiopharmaN/AN/AN/AN/A$4.43 per shareN/ANAOVNanovibronix$2.56M2.17N/AN/A$18.38 per share0.38Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBFRIBiofrontera-$17.76M-$2.26N/AN/AN/A-42.34%-1,104.09%-82.28%11/12/2025 (Estimated)IMACIMAC-$10.54MN/A0.00N/AN/A-75.40%-52.17%-34.51%N/AMTNBMatinas Biopharma-$22.94M-$3.89N/A∞N/AN/A-123.06%-94.28%N/ANAOVNanovibronix-$3.70M-$13.53N/A∞N/A-380.29%-45.24%-34.24%11/12/2025 (Estimated)Latest IMAC, MTNB, NAOV, and BFRI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/19/2025Q2 2025NAOVNanovibronixN/A-$1.03N/A-$1.03N/A$0.49 million8/13/2025Q2 2025BFRIBiofrontera-$0.45-$0.57-$0.12-$0.57$8.30 million$9.03 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBFRIBiofronteraN/AN/AN/AN/AN/AIMACIMACN/AN/AN/AN/AN/AMTNBMatinas BiopharmaN/AN/AN/AN/AN/ANAOVNanovibronixN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBFRIBiofrontera8.990.960.75IMACIMAC0.011.271.27MTNBMatinas BiopharmaN/A5.535.53NAOVNanovibronixN/A1.050.72Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBFRIBiofrontera10.08%IMACIMAC24.27%MTNBMatinas Biopharma11.77%NAOVNanovibronix16.39%Insider OwnershipCompanyInsider OwnershipBFRIBiofrontera4.80%IMACIMAC10.00%MTNBMatinas Biopharma4.60%NAOVNanovibronix6.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBFRIBiofrontera7010.14 million9.65 millionNo DataIMACIMAC10626.49 million23.84 millionNot OptionableMTNBMatinas Biopharma305.09 million4.60 millionN/ANAOVNanovibronix20800,000747,000Not OptionableIMAC, MTNB, NAOV, and BFRI HeadlinesRecent News About These CompaniesNanoVibronix files to sell 1.35M shares of common stock for holdersSeptember 16 at 10:15 PM | msn.comNanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesSeptember 16 at 3:57 PM | businesswire.comNanoVibronix stock soars after securing new U.S. patent for medical guidance systemSeptember 15 at 1:40 PM | za.investing.comNanoVibronix shares jump after new U.S. patent for medical device guidanceSeptember 15 at 1:40 PM | msn.comNanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical’s Intellectual Property PortfolioSeptember 15 at 8:39 AM | finance.yahoo.comNanoVibronix subsidiary granted patentSeptember 4, 2025 | msn.comNanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation TechnologySeptember 4, 2025 | finance.yahoo.comNanoVibronix Delays Q2 2025 10-Q FilingAugust 15, 2025 | msn.comNanoVibronix Inc trading halted, volatility trading pauseAugust 14, 2025 | msn.comNanoVibronix announces another reverse stock splitAugust 8, 2025 | massdevice.comNanoVibronix Appoints New Executive VP of FinanceAugust 2, 2025 | theglobeandmail.comNanoVibronix Secures $8 Million Through Securities AgreementJuly 24, 2025 | theglobeandmail.comNanoVibronix enters into $50M financing agreementJuly 18, 2025 | massdevice.comNanoVibronix adjourns special meeting due to lack of quorum ...July 12, 2025 | investing.comNanoVibronix corrects Series G Preferred Stock floor price in charter ...July 11, 2025 | investing.comNanoVibronix Announces ENvue Drive – First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation - MorningstarJune 27, 2025 | morningstar.comMNanoVibronix, Inc. (NAOV) - Yahoo FinanceJune 27, 2025 | finance.yahoo.comNanoVibronix Announces ENvue Drive – First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line NavigationJune 26, 2025 | finance.yahoo.comNanoVibronix has a next-gen robotic system under developmentJune 26, 2025 | massdevice.comNanoVibronix's ENvue Medical Division Announces Agreement with New York Medical Center to Implement ENvue™ Navigation Systems for Enteral Feeding Tube PlacementJune 24, 2025 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeIMAC, MTNB, NAOV, and BFRI Company DescriptionsBiofrontera NASDAQ:BFRI$0.85 -0.02 (-2.39%) Closing price 04:00 PM EasternExtended Trading$0.85 0.00 (-0.24%) As of 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.IMAC NASDAQ:IMAC$0.08 +0.00 (+4.17%) As of 09/16/2025IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.Matinas Biopharma NYSE:MTNB$1.65 -0.05 (-2.94%) Closing price 04:00 PM EasternExtended Trading$1.66 +0.02 (+0.91%) As of 04:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.Nanovibronix NASDAQ:NAOV$6.93 -0.72 (-9.41%) Closing price 04:00 PM EasternExtended Trading$6.96 +0.03 (+0.43%) As of 05:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike’s Red-Hot Analyst Buzz: Is a Comeback Brewing? Broadcom Hits Record High After CEO Hock Tan AI Pay Package CrowdStrike Stock Set for Breakout as Agentic AI Demand Surges Why CoreWeave's NVIDIA Deal Creates a Deep Moat for AI Investors Resideo Technologies: Institutional Activity Signals 30% Upside This Stock Quietly Benefits From Oracle and NVIDIA’s AI Surge Rezolute Stock: FDA Fast Track Fuels 2025 Breakout Lululemon’s Sell-Off Looks Overdone: A Contrarian Case Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
